| Schedule of basic and diluted net income (loss) per share |
Basic and diluted net income (loss) per share for the three and six months ended June 30, 2026 and 2025 was calculated as follows (in thousands except share and per share amounts). | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Numerator: | | | | | | | | | | | | | Net income (loss) attributable to common stockholders for basic and diluted net income (loss) per share | | $ | 39,389 | | $ | (16,643) | | $ | (37,777) | | $ | (32,078) | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | | | Weighted average number of common shares outstanding - basic | | | 184,328,441 | | | 41,444,979 | | | 176,260,808 | | | 41,357,423 | Weighted average effect of potentially dilutive securities: | | | | | | | | | | | | | Effect of potentially dilutive common stock warrants | | | 31,524,859 | | | — | | | — | | | — | Effect of potentially dilutive restricted stock units | | | 1,489,713 | | | — | | | — | | | — | Weighted average common shares outstanding — diluted | | | 217,343,013 | | | 41,444,979 | | | 176,260,808 | | | 41,357,423 | | | | | | | | | | | | | | Net income (loss) per share attributable to common stockholders: | | | | | | | | | | | | | Basic | | $ | 0.21 | | $ | (0.40) | | $ | (0.21) | | $ | (0.78) | Diluted | | $ | 0.18 | | $ | (0.40) | | $ | (0.21) | | $ | (0.78) |
|
| Schedule of potentially anti-dilutive securities excluded from calculation of diluted net income (loss) per share |
| | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Options to purchase common stock | | 3,745,572 | | 5,031,973 | | 3,745,572 | | 5,031,973 | Warrants to purchase common stock | | 1,921,854 | | 3,285,316 | | 77,907,459 | | 3,285,316 | Restricted stock units to purchase common stock | | 14,139,884 | | — | | 16,581,971 | | — | | | 19,807,310 | | 8,317,289 | | 98,235,002 | | 8,317,289 |
|